we presently report the results of a trial of mitoxantrone in combination with cytosine arabinoside ( ara-c ) in patients with refractory or relapsed acute myelocytic leukemia ( aml ) .
C0026259
mitoxantrone
C0023467
acute myelocytic leukemia